Modeling HIV-1 induced disruption of blood brain barrier integrity in mice
模拟 HIV-1 诱导小鼠血脑屏障完整性破坏
基本信息
- 批准号:8648207
- 负责人:
- 金额:$ 3.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-01 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS neuropathyAddressAdultAgonistAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAstrocytesBlood - brain barrier anatomyBlood PlateletsBrainBrain regionCD40 AntigensCell CountCerebrospinal FluidComplexDNADataDevelopmentDiseaseEndothelial CellsErinaceidaeExclusionExtravasationGenesGenetic TranscriptionGenomeGliomaHIVHIV-1HomeostasisHumanHypertrophyIn VitroIndividualInfectionInfiltrationInflammationInflammation MediatorsInjuryIntegration Host FactorsKnowledgeLifeLinkMeasuresMicroscopyModelingMurine leukemia virusMusNeuraxisNeurocognitiveNeurodegenerative DisordersNeurologicOncogenesPatientsPatternPeripheralPermeabilityPlasmaPlatelet ActivationPlayProcessProteinsProteolytic ProcessingRecruitment ActivityReportingResistanceRiskRoleSecondary toSignal TransductionSodium FluoresceinSonic Hedgehog PathwaySourceStaining methodStainsTNFRSF5 geneTNFSF5 geneTestingTracerTrans-ActivatorsUp-RegulationViralViral ProteinsVirionantiretroviral therapybrain tissuehuman SMO proteinimaging modalityin vivomigrationmonocytenew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspublic health relevancereceptortranscription factor
项目摘要
DESCRIPTION (provided by applicant): HIV-1 infected individuals on combination antiretroviral therapy (cART) are living longer than the pre-cART era, however these individuals are at an increased risk of developing neurocognitive disorders referred to as HIV-1-associated neurocognitive disorders (HAND). HIV-1 infects a great number of cells, yielding proviral DNA. And while cART reduces viral replication, it has no effect on these early viral gene products such as transactivator of transcription (Tat). Tat upregulates inflammatory mediators, stimulating peripheral monocytes to permeate into the central nervous system (CNS). The underlying mechanisms as to how monocytes are able to cross the blood brain barrier (BBB) remain elusive. Previously, our lab has shown that in HAND patients, their cerebrospinal fluid (CSF) and plasma contained abnormally high levels of soluble CD40L (sCD40L) and we have shown that mice injected with physiologically relevant concentrations of Tat had significantly greater levels of sCD40L in their plasma than non-treated mice. In addition, our lab has reported that CD40L receptor, CD40, were present on brain microvascular endothelial cells (BMVEC) and thus this interaction promoted the infiltration of monocytes across the BBB, in vitro. Further, our
in vivo studies revealed that Tat induces BBB permeability in mice in a CD40L dependent manner as a result of atypical activation of platelets, a major source of sCD40L, because BBB permeability is reversed after platelet depletion. Overall, these data provide me with a rational framework to test my hypothesis that the virally encoded proteins induce CD40-CD40L signaling to disrupt neurovascular homeostasis and thereby compromising BBB integrity, yielding subsequent neurologic damages that are consistent with the CNS manifestations associated with HAND. The development of new therapeutic approaches can be expected at the completion of this study to address HAND and possibly other neurocognitive disorders not HAND related.
描述(由申请人提供):接受联合抗逆转录病毒治疗 (cART) 的 HIV-1 感染者的寿命比 cART 之前的时代更长,但是这些人患神经认知障碍(称为 HIV-1 相关神经认知障碍)的风险增加疾病(手)。 HIV-1 感染大量细胞,产生原病毒 DNA。虽然 cART 减少病毒复制,但它对这些早期病毒基因产物(例如转录反式激活因子 (Tat))没有影响。 Tat 上调炎症介质,刺激外周单核细胞渗透到中枢神经系统 (CNS)。单核细胞如何穿过血脑屏障(BBB)的潜在机制仍然难以捉摸。此前,我们的实验室已经证明,在 HAND 患者中,他们的脑脊液 (CSF) 和血浆中含有异常高水平的可溶性 CD40L (sCD40L),并且我们已经证明,注射生理相关浓度的 Tat 的小鼠体内的 sCD40L 水平显着更高。血浆比未治疗的小鼠。此外,我们的实验室报告说,CD40L 受体 CD40 存在于脑微血管内皮细胞 (BMVEC) 上,因此这种相互作用在体外促进了单核细胞跨 BBB 的浸润。此外,我们的
体内研究表明,由于血小板(sCD40L 的主要来源)的非典型激活,Tat 以 CD40L 依赖性方式诱导小鼠 BBB 通透性,因为血小板耗尽后 BBB 通透性发生逆转。总的来说,这些数据为我提供了一个合理的框架来检验我的假设,即病毒编码的蛋白诱导 CD40-CD40L 信号传导破坏神经血管稳态,从而损害 BBB 完整性,产生与 HAND 相关的 CNS 表现一致的后续神经损伤。本研究完成后,预计将开发出新的治疗方法来解决 HAND 以及可能与 HAND 无关的其他神经认知障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Letitia Day Jones其他文献
Letitia Day Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Letitia Day Jones', 18)}}的其他基金
Modeling HIV-1 induced disruption of blood brain barrier integrity in mice
模拟 HIV-1 诱导小鼠血脑屏障完整性破坏
- 批准号:
8960951 - 财政年份:2013
- 资助金额:
$ 3.58万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Impact of HIV and cannabis on brain function: Regions, networks, and the connecto
艾滋病毒和大麻对大脑功能的影响:区域、网络和连接
- 批准号:
8732178 - 财政年份:2014
- 资助金额:
$ 3.58万 - 项目类别:
Transnasal Delivery of Chemokine Analogs in mouse NeuroAIDS Models
小鼠神经艾滋病模型中趋化因子类似物的经鼻递送
- 批准号:
8739326 - 财政年份:2013
- 资助金额:
$ 3.58万 - 项目类别:
Transnasal Delivery of Chemokine Analogs in mouse NeuroAIDS Models
小鼠神经艾滋病模型中趋化因子类似物的经鼻递送
- 批准号:
8658939 - 财政年份:2013
- 资助金额:
$ 3.58万 - 项目类别:
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
铂相关毒性的遗传易感性和生物标志物
- 批准号:
10466861 - 财政年份:2012
- 资助金额:
$ 3.58万 - 项目类别:
PDGF-BB Reverses Impaired Neurogenesis Mediated by Tat and Cocaine
PDGF-BB 逆转 Tat 和可卡因介导的受损神经发生
- 批准号:
8591388 - 财政年份:2012
- 资助金额:
$ 3.58万 - 项目类别: